Literature DB >> 1342957

Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma.

G Niedobitek1, H Herbst, L S Young, M Rowe, D Dienemann, C Germer, H Stein.   

Abstract

The Epstein-Barr virus (EBV) is associated with undifferentiated nasopharyngeal carcinomas (NPCs). Recently, EBV DNA has been demonstrated also in some cases of gastric carcinoma with similar morphology as undifferentiated NPC. Here we report on the expression of EBV genes in a gastric undifferentiated carcinoma of nasopharyngeal type (UCNT). The small EBV-encoded nuclear RNAs, EBERs, were expressed in all tumor cells. The BZLF1 transactivator protein, which disrupts viral latency, was detectable in a small subset of tumor cells. The latent membrane protein and the nuclear antigen EBNA2 were not expressed. These results indicate that lytic EBV infection may be possible in undifferentiated epithelial cells. Our findings add to the growing body of evidence suggesting a strong association of gastric UCNT with EBV and point to the possibility of an involvement of the virus in the pathogenesis of this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342957

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  16 in total

1.  Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Authors:  Rachel M Temple; Junjia Zhu; Lynn Budgeon; Neil David Christensen; Craig Meyers; Clare E Sample
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

2.  Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan.

Authors:  Jun-ichi Miyagi; Takayoshi Toda; Hiroshi Uezato; Kouichi Ohshima; Tsuyoshi Miyakuni; Nobuyuki Takasu; Masato Masuda
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

Review 3.  The Epstein-Barr virus and its association with human cancers.

Authors:  K R Baumforth; L S Young; K J Flavell; C Constandinou; P G Murray
Journal:  Mol Pathol       Date:  1999-12

4.  Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.

Authors:  Jun Zhang; Lin Jia; Weitao Lin; Yim Ling Yip; Kwok Wai Lo; Victoria Ming Yi Lau; Dandan Zhu; Chi Man Tsang; Yuan Zhou; Wen Deng; Hong Lok Lung; Maria Li Lung; Lai Man Cheung; Sai Wah Tsao
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa.

Authors:  S Shousha; Y A Luqmani
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

6.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Authors:  Claire Shannon-Lowe; Emily Adland; Andrew I Bell; Henri-Jacques Delecluse; Alan B Rickinson; Martin Rowe
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

8.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Authors:  Q N Vo; J Geradts; M L Gulley; D A Boudreau; J C Bravo; B G Schneider
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

9.  Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.

Authors:  Hao-Ping Liu; Chia-Chun Chen; Chih-Ching Wu; Yi-Chuan Huang; Shu-Chen Liu; Ying Liang; Kai-Ping Chang; Yu-Sun Chang
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

10.  Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.

Authors:  D C Rowlands; M Ito; D C Mangham; G Reynolds; H Herbst; M T Hallissey; J W Fielding; K M Newbold; E L Jones; L S Young
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.